Skip to main content
SpringerLink
Log in

Switch to oxymorphone cost saving for chronic pain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Magar RS, Fine PG, White RE.Expected cost and cost considerations associated with opioid rotation for chronic non-cancer pain: a simulation model. Value in Health 10: A464 (plus poster) abstr. PPN3, No. 6, Nov-Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Switch to oxymorphone cost saving for chronic pain. Pharmacoecon. Outcomes News 541, 8 (2007). https://doi.org/10.2165/00151234-200705410-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705410-00012

Keywords

Search

Navigation